PCN72 An EARLY Cost-Effectiveness Analysis of Xevinapant in Combination with Chemo-Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck in United States.
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.164
https://www.valueinhealthjournal.com/article/S1098-3015(21)00381-8/fulltext
Title :
PCN72 An EARLY Cost-Effectiveness Analysis of Xevinapant in Combination with Chemo-Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck in United States.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00381-8&doi=10.1016/j.jval.2021.04.164
First page :
Section Title :
Open access? :
No
Section Order :
10744